AMRXAmneal Pharmaceuticals, Inc.

$17.99

Who owns AMRX

313 institutions reported holding AMRX for 2026Q1, together 49% of the company, more than the 275 a quarter earlier.

313

Institutions reporting a position · as of 2026Q1 · up from 275 the quarter before

Shares held by institutions
159.8M

Shares held by institutions · 49% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.99B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
23%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
32
New positions
70
Positions exited
39
Added to
112
Reduced
73
Top 10 holdersof the company
29%
Institutional ownership by quarter, 2018Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q1313159.8M$1.99B
2025Q4275154.2M$1.94B
2025Q3244150.0M$1.50B
2025Q2238142.2M$1.15B
2025Q1235135.4M$1.13B
2024Q4198126.1M$999M
2024Q3183142.7M$1.19B
2024Q2181138.6M$880M
2024Q1175108.1M$655M
2023Q4152109.2M$663M
2023Q3143101.9M$430M
2023Q212897.5M$302M
2023Q114396.8M$135M
2022Q4155101.9M$205M
2022Q315499.6M$203M
2022Q215199.4M$316M
Largest reported holders, 2026Q1
HolderShares% of companyValue
BlackRock Inc.24.5M7.5%$305M
VANGUARD GROUP INC20.3M6.2%$253M
TPG GP A, LLC12.3M3.7%$153M
Rubric Capital Management LP11.0M3.4%$137M
STATE STREET CORP6.8M2.1%$84M
DIMENSIONAL FUND ADVISORS LP5.7M1.7%$71M
MORGAN STANLEY4.6M1.4%$58M
GEODE CAPITAL MANAGEMENT LLC4.5M1.4%$57M
Neuberger Berman Group LLC3.7M1.1%$46M
Nuveen Asset Management, LLC3.2M0.99%$40M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…